The challenge of reducing smoking in people with serious mental illness

The Lancet Respiratory Medicine

Volumn 4, Issue 10, 2016, Pages 835-844

  Sharma, Ratika ^a   Gartner, Coral E ^a,b   Hall, Wayne D ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTRONIC CIGARETTE; HEALTH CARE POLICY; HOSPITAL DISCHARGE; HUMAN; MENTAL DISEASE; MORBIDITY; MORTALITY; NICOTINE REPLACEMENT THERAPY; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; PSYCHIATRIC TREATMENT; REVIEW; RISK FACTOR; SMOKING; SMOKING BAN; SMOKING CESSATION; SOCIAL SUPPORT; PSYCHOLOGY; SMOKING REDUCTION;

HUMANS; MENTAL DISORDERS; SMOKING CESSATION; SMOKING REDUCTION;

EID: 84989854401     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)30228-4     Document Type: Review

References (132)

1. 1 SAMHSA. Mental and substance use disorders. http://www.samhsa.gov/disorders, 2016 (accessed May 30, 2016).
2. 2 Olfson, M, Gerhard, T, Huang, C, Crystal, S, Stroup, TS, Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 72 (2015), 1172–1181.
3. 3 Horvitz-Lennon, M, Kilbourne, AM, Pincus, HA, From silos to bridges: meeting the general health care needs of adults with severe mental illnesses. Health Aff (Millwood) 25 (2006), 659–669.
4. 4 de Leon, J, Diaz, FJ, Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings. Hum Genet 131 (2012), 877–901.
5. 5 de Leon, J, Diaz, FJ, A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76 (2005), 135–157.
6. 6 Jackson, JG, Diaz, FJ, Lopez, L, de Leon, J, A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disord 17 (2015), 575–597.
7. 7 Glassman, AH, Helzer, JE, Covey, LS, et al. Smoking, smoking cessation, and major depression. JAMA 264 (1990), 1546–1549.
8. 8 Daumit, GL, Goff, DC, Meyer, JM, et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res 105 (2008), 175–187.
9. 9 Lawrence, D, Kisely, S, Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol 24 (2010), 61–68.
10. 10 Thornicroft, G, Premature death among people with mental illness. BMJ, 346, 2013, f2969.
11. 11 Mueser, KT, Yarnold, PR, Bellack, AS, Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand 85 (1992), 48–55.
12. 12 Hartz, SM, Pato, CN, Medeiros, H, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 71 (2014), 248–254.
13. 13 Prochaska, JJ, Delucchi, K, Hall, SM, A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol 72 (2004), 1144–1156.
14. 14 Kalman, D, Morissette, SB, George, TP, Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14 (2005), 106–123.
15. 15 Dickey, B, Normand, SL, Weiss, RD, Drake, RE, Azeni, H, Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 53 (2002), 861–867.
16. 16 Manzella, F, Maloney, SE, Taylor, GT, Smoking in schizophrenic patients: a critique of the self-medication hypothesis. World J Psychiatry 5 (2015), 35–46.
17. 17 Parikh, V, Kutlu, MG, Gould, TJ, nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: current trends and perspectives. Schizophr Res 171 (2016), 1–15.
18. 18 Gurillo, P, Jauhar, S, Murray, RM, MacCabe, JH, Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry 2 (2015), 718–725.
19. 19 Kendler, KS, Neale, MC, MacLean, CJ, Heath, AC, Eaves, LJ, Kessler, RC, Smoking and major depression. A causal analysis. Arch Gen Psychiatry 50 (1993), 36–43.
20. 20 Gregg, L, Barrowclough, C, Haddock, G, Reasons for increas ed substance use in psychosis. Clin Psychol Rev 27 (2007), 494–510.
21. 21 Evans, DE, Drobes, DJ, Nicotine self-medication of cognitive-attentional processing. Addict Biol 14 (2009), 32–42.
22. 22 Williams, JM, Ziedonis, D, Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 29 (2004), 1067–1083.
23. 23 Martinez-Raga, J, Keaney, F, Sutherland, G, Perez-Galvez, B, Strang, J, Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile. Addict Biol 8 (2003), 13–21.
24. 24 Hughes, JR, Stead, LF, Lancaster, T, Nortriptyline for smoking cessation: a review. Nicotine Tob Res 7 (2005), 491–499.
25. 25 Taylor, G, McNeill, A, Girling, A, Farley, A, Lindson-Hawley, N, Aveyard, P, Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ, 348, 2014, g1151.
26. 26 Hughes, JR, Stead, LF, Hartmann-Boyce, J, Cahill, K, Lancaster, T, Antidepressants for smoking cessation. Cochrane Database Syst Rev, 1, 2014 CD000031.
27. 27 Drake, RE, Cotton, PG, Depression, hopelessness and suicide in chronic schizophrenia. Br J Psychiatry 148 (1986), 554–559.
28. 28 Olincy, A, Freedman, R, Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor. Handb Exp Pharmacol 213 (2012), 211–232.
29. 29 George, TP, Termine, A, Sacco, KA, et al. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res 87 (2006), 307–315.
30. 30 Woznica, AA, Sacco, KA, George, TP, Prepulse inhibition deficits in schizophrenia are modified by smoking status. Schizophr Res 112 (2009), 86–90.
31. 31 Goff, DC, Henderson, DC, Amico, E, Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 149 (1992), 1189–1194.
32. 32 Kumari, V, Postma, P, Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29 (2005), 1021–1034.
33. 33 Kelly, C, McCreadie, R, Cigarette smoking and schizophrenia. Adv Psychiatr Treat 6 (2000), 327–331.
34. 34 Matthews, AM, Wilson, VB, Mitchell, SH, The role of antipsychotics in smoking and smoking cessation. CNS Drugs 25 (2011), 299–315.
35. 35 de Leon, J, Diaz, FJ, Aguilar, MC, Jurado, D, Gurpegui, M, Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis. Schizophr Res 86 (2006), 256–268.
36. 36 Boden, JM, Fergusson, DM, Norwood, LJ, Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br JPsychiatry 196 (2010), 440–446.
37. 37 Wu, LT, Anthony, JC, Tobacco smoking and depressed mood in late childhood and early adolescence. Am J Public Health 89 (1999), 1837–1840.
38. 38 Malone, KM, Waternaux, C, Haas, GL, Cooper, TB, Li, S, Mann, JJ, Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry 160 (2003), 773–779.
39. 39 Breslau, N, Peterson, EL, Schultz, LR, Chilcoat, HD, Andreski, P, Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry 55 (1998), 161–166.
40. 40 Taylor, AE, Fluharty, ME, Bjørngaard, JH, et al. Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium. BMJ Open, 4, 2014, e006141.
41. 41 Dani, JA, Roles of dopamine signaling in nicotine addiction. Mol Psychiatry 8 (2003), 255–256.
42. 42 Lau, CI, Wang, HC, Hsu, JL, Liu, ME, Does the dopamine hypothesis explain schizophrenia?. Rev Neurosci 24 (2013), 389–400.
43. 43 Myles, N, Newall, H, Compton, MT, Curtis, J, Nielssen, O, Large, M, The age at onset of psychosis and tobacco use: a systematic meta-analysis. Soc Psychiatry Psychiatr Epidemiol 47 (2012), 1243–1250.
44. 44 Bélanger, RE, Akre, C, Kuntsche, E, Gmel, G, Suris, JC, Adding tobacco to cannabis—its frequency and likely implications. Nicotine Tob Res 13 (2011), 746–750.
45. 45 Sherif, M, Radhakrishnan, R, D'Souza, DC, Ranganathan, M, Human laboratory studies on cannabinoids and psychosis. Biol Psychiatry 79 (2016), 526–538.
46. 46 Dierker, LC, Avenevoli, S, Stolar, M, Merikangas, KR, Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry 159 (2002), 947–953.
47. 47 Chambers, RA, Krystal, JH, Self, DW, A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50 (2001), 71–83.
48. 48 Faraone, SV, Su, J, Taylor, L, Wilcox, M, Van Eerdewegh, P, Tsuang, MT, A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families. Hum Hered 57 (2004), 59–68.
49. 49 Chen, JC, Bacanu, SA, Yu, H, et al. Genetic relationship between schizophrenia and nicotine dependence. Sci Rep, 6, 2016, 25671.
50. 50 McEachin, RC, Saccone, NL, Saccone, SF, et al. Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder. BMC Med Genet, 11, 2010, 14.
51. 51 Martinez-Ortega, JM, Goldstein, BI, Gutiérrez-Rojas, L, Sala, R, Wang, S, Blanco, C, Temporal sequencing of nicotine dependence and bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Psychiatr Res 47 (2013), 858–864.
52. 52 Heffner, JL, Strawn, JR, DelBello, MP, Strakowski, SM, Anthenelli, RM, The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disord 13 (2011), 439–453.
53. 53 de Leon, J, Diaz, FJ, A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76 (2005), 135–157.
54. 54 Dalack, GW, Becks, L, Hill, E, Pomerleau, OF, Meador-Woodruff, JH, Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 21 (1999), 195–202.
55. 55 Lyon, ER, A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv 50 (1999), 1346–1350.
56. 56 Covey, LS, Glassman, AH, Stetner, F, Cigarette smoking and major depression. J Addict Dis 17 (1998), 35–46.
57. 57 Cook, BL, Wayne, GF, Kafali, EN, Liu, Z, Shu, C, Flores, M, Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA 311 (2014), 172–182.
58. 58 de Leon, J, Becona, E, Gurpegui, M, Gonzalez-Pinto, A, Diaz, FJ, The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry 63 (2002), 812–816.
59. 59 Smith, PH, Homish, GG, Giovino, GA, Kozlowski, LT, Cigarette smoking and mental illness: a study of nicotine withdrawal. Am J Public Health 104 (2014), e127–e133.
60. 60 Shu, C, Cook, BL, Examining the association between substance use disorder treatment and smoking cessation. Addiction 110 (2015), 1015–1024.
61. 61 Siru, R, Hulse, GK, Tait, RJ, Assessing motivation to quit smoking in people with mental illness: a review. Addiction 104 (2009), 719–733.
62. 62 Prochaska, JJ, Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction?. Drug Alcohol Depend 110 (2010), 177–182.
63. 63 Ferron, JC, Brunette, MF, He, X, Xie, H, McHugo, GJ, Drake, RE, Course of smoking and quit attempts among clients with co-occurring severe mental illness and substance use disorders. Psychiatr Serv 62 (2011), 353–359.
64. 64 The Royal Australian College of General Practitioners. Supporting smoking cessation: a guide for health professionals. http://www.racgp.org.au/your-practice/guidelines/smoking-cessation/, 2014 (accessed Aug 22, 2016).
65. 65 Rüther, T, Bobes, J, De Hert, M, et al. EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry 29 (2014), 65–82.
66. 66 Roberts, E, Eden Evins, A, McNeill, A, Robson, D, Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction 111 (2016), 599–612.
67. 67 NICE. Smoking: acute, maternity and mental health services. https://www.nice.org.uk/guidance/ph48, 2013 (accessed Feb 10, 2016).
68. 68 Stead, LF, Perera, R, Bullen, C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 11, 2012 CD000146.
69. 69 Cahill, K, Stead, LF, Lancaster, T, Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev, 3, 2008 CD006103.
70. 70 Tidey, JW, Miller, ME, Smoking cessation and reduction in people with chronic mental illness. BMJ, 351, 2015, h4065.
71. 71 Horst, WD, Klein, MW, Williams, D, Werder, SF, Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia. Neuropsychiatr Dis Treat 1 (2005), 349–355.
72. 72 Baker, A, Richmond, R, Haile, M, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry 163 (2006), 1934–1942.
73. 73 Bryant, J, Bonevski, B, Paul, C, McElduff, P, Attia, J, A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction 106 (2011), 1568–1585.
74. 74 Evins, AE, Cather, C, Laffer, A, Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harv Rev Psychiatry 23 (2015), 90–98.
75. 75 Banham, L, Gilbody, S, Smoking cessation in severe mental illness: what works?. Addiction 105 (2010), 1176–1189.
76. 76 Stead, LF, Lancaster, T, Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev, 10, 2012 CD008286.
77. 77 Civljak, M, Stead, LF, Hartmann-Boyce, J, Sheikh, A, Car, J, Internet-based interventions for smoking cessation. Cochrane Database Syst Rev, 2013 CD007078.
78. 78 Sharma, R, Lucas, M, Ford, P, Meurk, C, Gartner, CE, YouTube as a source of quit smoking information for people living with mental illness. Tob Control, 2016, 10.1136/tobaccocontrol-2015-052713 published online Jan 12.
79. 79 Whittaker, R, Borland, R, Bullen, C, Lin, RB, McRobbie, H, Rodgers, A, Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev, 2009 CD006611.
80. 80 Stuyt, EB, Enforced abstinence from tobacco during in-patient dual-diagnosis treatment improves substance abuse treatment outcomes in smokers. Am J Addict 24 (2015), 252–257.
81. 81 Fichtenberg, CM, Glantz, SA, Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ, 325, 2002, 188.
82. 82 Longo, DR, Brownson, RC, Kruse, RL, Smoking bans in US hospitals. Results of a national survey. JAMA 274 (1995), 488–491.
83. 83 Freund, M, Campbell, E, Paul, C, Sakrouge, R, Wiggers, J, Smoking care provision in smoke-free hospitals in Australia. Prev Med 41 (2005), 151–158.
84. 84 Lawn, S, Pols, R, Smoking bans in psychiatric inpatient settings? A review of the research. Aust N Z J Psychiatry 39 (2005), 866–885.
85. 85 Wye, PM, Bowman, JA, Wiggers, JH, et al. Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia. Psychiatr Serv 60 (2009), 100–107.
86. 86 McAllister, M, Halliday, L, Jobson, H, et al. A mountain not too high to climb: a qualitative study exploring facilitators and barriers to smoking cessation in a regional mental health service. Adv Ment Health 14 (2015), 26–37.
87. 87 Lawn, S, Campion, J, Achieving smoke-free mental health services: lessons from the past decade of implementation research. Int J Environ Res Public Health 10 (2013), 4224–4244.
88. 88 Tobacco in Australia. Smoking bans in key public areas and environments. http://www.tobaccoinaustralia.org.au/15-4-overview-of-key-public-areas-and-environments#x35, 2016 (accessed Feb 11, 2016).
89. 89 National Mental Health Consumer and Carer Forum. Smoking and mental health. https://nmhccf.org.au/sites/default/files/docs/nmhccf_-_advoacy_brief_-_smoking_-_february_2014.pdf, 2014 (accessed Jan 17, 2016).
90. 90 Brown-Johnson, CG, Sanders-Jackson, A, Prochaska, JJ, Online comments on smoking bans in psychiatric hospitals units. J Dual Diagn 10 (2014), 204–211.
91. 91 Chapman, S, A complete smoking ban in psychiatric hospitals is ethically wrong. BMJ, 351, 2015, h6288.
92. 92 Chapman, S, Prisoners should be free to smoke outside. http://www.smh.com.au/comment/prisoners-should-be-free-to-smoke-outside-20130930-2uo4f.html, 2013 (accessed Jan 17, 2016).
93. 93 Arnott, D, Wessely, S, Fitzpatrick, M, Should psychiatric hospitals completely ban smoking?. BMJ, 351, 2015, h5654.
94. 94 Lawn, SJ, Systemic barriers to quitting smoking among institutionalised public mental health service populations: a comparison of two Australian sites. Int J Soc Psychiatry 50 (2004), 204–215.
95. 95 Subramaniam, A, Smoking ban in psychiatric wards raises safety and ethical issues. Australas Psychiatry 23 (2015), 310–311.
96. 96 Velasco, J, Eells, TD, Anderson, R, et al. A two-year follow-up on the effects of a smoking ban in an inpatient psychiatric service. Psychiatr Serv 47 (1996), 869–871.
97. 97 Rauter, UK, de Nesnera, A, Grandfield, S, Up in smoke? Linking patient assaults to a psychiatric hospital's smoking ban. J Psychosoc Nurs Ment Health Serv 35 (1997), 35–40.
98. 98 Meyer, JM, Individual changes in clozapine levels after smoking cessation: results and a predictive model. J Clin Psychopharmacol 21 (2001), 569–574.
99. 99 de Leon, J, Atypical antipsychotic dosing: the effect of smoking and caffeine. Psychiatr Serv 55 (2004), 491–493.
100. 100 Prochaska, JJ, Fletcher, L, Hall, SE, Hall, SM, Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict 15 (2006), 15–22.
101. 101 Lawn, S, Campion, J, Factors associated with success of smoke-free initiatives in Australian psychiatric inpatient units. Psychiatr Serv 61 (2010), 300–305.
102. 102 Schuck, RK, Dahl, A, Hall, SM, et al. Smokers with serious mental illness and requests for nicotine replacement therapy post-hospitalisation. Tob Control 25 (2016), 27–32.
103. 103 Sohal, H, Huddlestone, L, Ratschen, E, Preparing for completely smoke-free mental health settings: findings on patient smoking, resources spent facilitating smoking breaks, and the role of smoking in reported incidents from a large mental health trust in England. Int J Environ Res Public Health, 13, 2016, 256.
104. 104 Fairchild, AL, Bayer, R, Colgrove, J, The renormalization of smoking? E-cigarettes and the tobacco “endgame”. N Engl J Med 370 (2014), 293–295.
105. 105 Chapman, S, E-cigarettes: the best and the worst case scenarios for public health—an essay by Simon Chapman. BMJ, 349, 2014, g5512.
106. 106 Douglas, H, Hall, W, Gartner, C, E-cigarettes and the law in Australia. Aust Fam Physician 44 (2015), 415–418.
107. 107 Johns Hopkins Bloomberg School of Public Health. Country laws regulating e-cigarettes: a policy scan. http://globaltobaccocontrol.org/node/14052, 2016 (accessed July 14, 2016).
108. 108 Addy, N, Levin, ED, Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. Neuropsychopharmacology 27 (2002), 534–541.
109. 109 Levin, ED, Rezvani, AH, Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. Biochem Pharmacol 74 (2007), 1182–1191.
110. 110 Faber, MS, Fuhr, U, Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 76 (2004), 178–184.
111. 111 Lawrence, D, Hafekost, J, Hull, P, Mitrou, F, Zubrick, SR, Smoking, mental illness and socioeconomic disadvantage: analysis of the Australian National Survey of Mental Health and Wellbeing. BMC Public Health, 13, 2013, 462.
112. 112 Zhou, X, Nonnemaker, J, Sherrill, B, Gilsenan, AW, Coste, F, West, R, Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav 34 (2009), 365–373.
113. 113 Boardman, T, Catley, D, Mayo, MS, Ahluwalia, JS, Self-efficacy and motivation to quit during participation in a smoking cessation program. Int J Behav Med 12 (2005), 266–272.
114. 114 Hall, W, Gartner, C, Forlini, C, Ethical issues raised by a ban on the sale of electronic nicotine devices. Addiction 110 (2015), 1061–1067.
115. 115 Gartner, C, Hall, W, Tobacco harm reduction in people with serious mental illnesses. Lancet Psychiatry 2 (2015), 485–487.
116. 116 Chen, HK, Lan, TH, Wu, BJ, A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 263 (2013), 75–82.
117. 117 O'Brien, B, Knight-West, O, Walker, N, Parag, V, Bullen, C, E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial. Tob Induc Dis, 13, 2015, 5.
118. 118 Caponnetto, P, Auditore, R, Russo, C, Cappello, GC, Polosa, R, Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 10 (2013), 446–461.
119. 119 Perez-Iglesias, R, McNeill, A, Dawkins, L, Moxham, J, McGuire, P, Electronic cigarettes in smokers with mental illness (APUS e-Cigs). https://clinicaltrials.gov/ct2/show/NCT02212041?term=Schizophrenia+AND+e-cigarette&rank=1, 2014 (accessed Feb 22, 2016).
120. 120 VicHealth. Vaporising smoking-related harms in people with severe and persistent mental illness: a study of the acceptability of vaporised nicotine products for smoking cessation or long term substitutes. https://www.vichealth.vic.gov.au/programs-and-projects/2014-vichealth-innovation-research-grant-recipients-and-project-summaries, 2015 (accessed March 3, 2016).
121. 121 Farsalinos, KE, Tsiapras, D, Kyrzopoulos, S, Savvopoulou, M, Voudris, V, Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord, 14, 2014, 78.
122. 122 Farsalinos, KE, Romagna, G, Tsiapras, D, Kyrzopoulos, S, Voudris, V, Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health 11 (2014), 4356–4373.
123. 123 Walele, T, Sharma, G, Savioz, R, Martin, C, Williams, J, A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: safety and subjective effects. Regul Toxicol Pharmacol 74 (2016), 193–199.
124. 124 Gartner, CE, Hall, WD, Vos, T, Bertram, MY, Wallace, AL, Lim, SS, Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 369 (2007), 2010–2014.
125. 125 Hatsukami, DK, Severson, H, Anderson, A, et al. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching. Tob Control 25 (2016), 267–274.
126. 126 Phillips, CV, Heavner, KK, Smokeless tobacco: the epidemiology and politics of harm. Biomarkers 14:suppl 1 (2009), 79–84.
127. 127 Patel, MX, Doku, V, Tennakoon, L, Challenges in recruitment of research participants. Adv Psychiatr Treat 9 (2003), 229–238.
128. 128 González-Torres, MA, Oraa, R, Arístegui, M, Fernández-Rivas, A, Guimon, J, Stigma and discrimination towards people with schizophrenia and their family members. Soc Psychiatry Psychiatr Epidemiol 42 (2007), 14–23.
129. 129 Tsoi, DT, Porwal, M, Webster, AC, Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev, 2, 2013 CD007253.
130. 130 Thornicroft, G, Brohan, E, Rose, D, Sartorius, N, Leese, M, INDIGO Study Group. Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet 373 (2009), 408–415.
131. 131 Bryant, J, Bonevski, B, Paul, C, O'Brien, J, Oakes, W, Delivering smoking cessation support to disadvantaged groups: a qualitative study of the potential of community welfare organizations. Health Educ Res 25 (2010), 979–990.
132. 132 Weinberger, AH, Smoking cessation and adults with serious mental illness: the need for more research at every step of the quit process. Nicotine Tob Res 18 (2016), 227–228.